Literature DB >> 18849906

Obsessive-compulsive disorder spectrum as a scientific "metaphor".

Stefano Pallanti1, Eric Hollander.   

Abstract

As a result of clinical, epidemiological, neuroimaging, and therapy studies that took place in the late 1980s, obsessive-compulsive disorder (OCD) has been well-characterized in the field of anxiety disorders. Other disorders attracted attention for their similarities to OCD, and were located in the orbit of the disorder. OCD has become known as the "primary domain" of a scientific "metaphor" comprising the putative cluster of OCD-related disorders (OCRDs). It is a "paradigm" with which to explore basal ganglia dysfunction. The OCRDs share common phenomenology, comorbidities, lifetime course, demographics, possible genetics, and frontostriatal dysfunction (particularly caudate hyperactivity.) The adoption of this metaphor analogy has proven useful. However, 15 years since its emergence, the spectrum of obsessive-compulsive disorders remains controversial. Questions under debate include whether OCD is a unitary or split condition, whether it is an anxiety disorder, and whether there exists only one spectrum or several possible spectrums. Further work is needed to clarify obsessive-compulsive symptoms, subtypes, and endophenotypes. There is need to integrate existing databases, better define associated symptom domains, and create a more comprehensive endophenotyping protocol for OCRDs. There is also a need to integrate biological and psychological perspectives, concepts, and data to drive this evolution. By increasing research in this field, the OCD spectrum may evolve from a fragmented level of conceptualization as a "metaphor" to one that is more comprehensive and structured.

Entities:  

Mesh:

Year:  2008        PMID: 18849906     DOI: 10.1017/s1092852900026882

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  6 in total

1.  Are obsessive-compulsive symptoms impulsive, compulsive or both?

Authors:  Samuel R Chamberlain; Eric W Leppink; Sarah A Redden; Jon E Grant
Journal:  Compr Psychiatry       Date:  2016-04-15       Impact factor: 3.735

2.  Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.

Authors:  Silvia Cabrini; Mario Baratti; Flavio Bonfà; Giulio Cabri; Elena Uber; Maurizio Avanzi
Journal:  Neurol Sci       Date:  2009-06-10       Impact factor: 3.307

3.  COMT and MAO-A polymorphisms and obsessive-compulsive disorder: a family-based association study.

Authors:  Aline Santos Sampaio; Ana Gabriela Hounie; Kátia Petribú; Carolina Cappi; Ivanil Morais; Homero Vallada; Maria Conceição do Rosário; S Evelyn Stewart; Jesen Fargeness; Carol Mathews; Paul Arnold; Gregory L Hanna; Margaret Richter; James Kennedy; Leonardo Fontenelle; Carlos Alberto de Bragança Pereira; David L Pauls; Eurípedes Constantino Miguel
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  Inhibition-Related Cortical Hypoconnectivity as a Candidate Vulnerability Marker for Obsessive-Compulsive Disorder.

Authors:  Adam Hampshire; Ana Zadel; Stefano Sandrone; Eyal Soreq; Naomi Fineberg; Edward T Bullmore; Trevor W Robbins; Barbara J Sahakian; Samuel R Chamberlain
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-10-16

Review 5.  The Role of SliTrk5 in Central Nervous System.

Authors:  Yan Liu; Linming Zhang; Rong Mei; Mingda Ai; Ruijing Pang; Di Xia; Ling Chen; Lianmei Zhong
Journal:  Biomed Res Int       Date:  2022-07-14       Impact factor: 3.246

6.  Brain micro-architecture and disinhibition: a latent phenotyping study across 33 impulsive and compulsive behaviours.

Authors:  Jon E Grant; Edward T Bullmore; Murat Yücel; Rafa Romero-Garcia; Roxanne W Hook; Jeggan Tiego; Richard A I Bethlehem; Ian M Goodyer; Peter B Jones; Ray Dolan; Samuel R Chamberlain
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.